StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3028% above fair value
$692.74+5.95 (+0.87%)

Close on Nov 18, 2026Market cap $256.67BP/E 36.6Yield 0.25%

Thermo Fisher Scientific Restructuring Costs by Quarter

Restructuring Costs — Laboratory Products & Biopharma Services ($M)

Thermo Fisher Scientific Restructuring Costs: $62M in Q2 2026, up 10.7% from a year earlier.

Latest, Q2 2026
62
Period ended Jun 30, 2026
Change on a year earlier
+10.7%
56 in Q2 2025
History
6 quarters
Since Q1 2025
Sources
6
Documents cited below

Where the Q2 2026 figure comes from

“|| Laboratory Products and Biopharma Services | 62 | 95”

Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗

Reported in SEC 10-K / 10-Q Note 14.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestructuring Costs — Laboratory Products & Biopharma Services ($M)Year on yearSource
Q2 2026Jun 30, 202662+10.7%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2026Mar 31, 202633-26.7%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q4 2025Dec 31, 20258–SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2025Sep 30, 202539–SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2025Jun 30, 202556–SEC Form 10-Q (10q_2025Q2, filed 2025-08-01) ↗
Q1 2025Mar 31, 202545–SEC Form 10-Q (10q_2025Q1, filed 2025-05-02) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Restructuring Costs ($M), quarterly Q1 2025–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/restruct-lpbs

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.

See a number that looks wrong?